1 stock that could rise 175%, according to Wall Street
Viking Therapeutics’ price target implies a juicy upside to current levels. The stock’s biggest catalysts will likely have to wait until next year. The drug maker is somewhat risky, but could offer massive profits. 10 Stocks We Like More Than Viking Therapeutics › Last year was a challenging one for Viking therapeutics (NASDAQ: VKTX)a mid-cap … Read more